EKTTITAB Stock Overview
Ekttitab Holding Company K.S.C Public engages in the investment activities in Kuwait.
Ekttitab Holding Company K.S.C Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||د.ك0.011|
|52 Week High||د.ك0.024|
|52 Week Low||د.ك0.0088|
|1 Month Change||-8.07%|
|3 Month Change||-8.07%|
|1 Year Change||-39.04%|
|3 Year Change||-31.32%|
|5 Year Change||-67.43%|
|Change since IPO||-96.98%|
Recent News & Updates
|EKTTITAB||KW Capital Markets||KW Market|
Return vs Industry: EKTTITAB underperformed the KW Capital Markets industry which returned -1.7% over the past year.
Return vs Market: EKTTITAB underperformed the KW Market which returned 4% over the past year.
|EKTTITAB Average Weekly Movement||10.7%|
|Capital Markets Industry Average Movement||5.0%|
|Market Average Movement||4.9%|
|10% most volatile stocks in KW Market||9.5%|
|10% least volatile stocks in KW Market||2.3%|
Stable Share Price: EKTTITAB is more volatile than 90% of KW stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: EKTTITAB's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KW stocks.
About the Company
Ekttitab Holding Company K.S.C Public engages in the investment activities in Kuwait. The company was founded in 1999 and is headquartered in Kuwait City, Kuwait.
Ekttitab Holding Company K.S.C Fundamentals Summary
|EKTTITAB fundamental statistics|
Is EKTTITAB overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EKTTITAB income statement (TTM)|
|Cost of Revenue||د.ك0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.0061|
|Net Profit Margin||-23,904.92%|
How did EKTTITAB perform over the long term?See historical performance and comparison
Is EKTTITAB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EKTTITAB?
Other financial metrics that can be useful for relative valuation.
|What is EKTTITAB's n/a Ratio?|
Price to Book Ratio vs Peers
How does EKTTITAB's PB Ratio compare to its peers?
|EKTTITAB PB Ratio vs Peers|
|Company||PB||Estimated Growth||Market Cap|
WARBACAP Warba Capital Holding Company K.S.C.P
OSOUL Osoul Investment Company - K.S.C.P
BAYANINV Bayan Investment Holding Company (K.S.C)
UNICAP Unicap Investment and Finance Company K.S.C.P
EKTTITAB Ekttitab Holding Company K.S.C
Price-To-Book vs Peers: EKTTITAB is good value based on its Price-To-Book Ratio (0.4x) compared to the peer average (0.7x).
Price to Earnings Ratio vs Industry
How does EKTTITAB's PE Ratio compare vs other companies in the KW Capital Markets Industry?
Price-To-Book vs Industry: EKTTITAB is good value based on its Price-To-Book Ratio (0.4x) compared to the KW Capital Markets industry average (0.7x)
Price to Book Ratio vs Fair Ratio
What is EKTTITAB's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PB Ratio||0.4x|
|Fair PB Ratio||n/a|
Price-To-Book vs Fair Ratio: Insufficient data to calculate EKTTITAB's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of EKTTITAB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate EKTTITAB's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate EKTTITAB's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Ekttitab Holding Company K.S.C forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Diversified Financials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ekttitab Holding Company K.S.C has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine Ekttitab Holding Company K.S.C's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
How has Ekttitab Holding Company K.S.C performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EKTTITAB is currently unprofitable.
Growing Profit Margin: EKTTITAB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EKTTITAB is unprofitable, and losses have increased over the past 5 years at a rate of 5.9% per year.
Accelerating Growth: Unable to compare EKTTITAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EKTTITAB is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (15.4%).
Return on Equity
High ROE: EKTTITAB has a negative Return on Equity (-19.97%), as it is currently unprofitable.
Discover strong past performing companies
How is Ekttitab Holding Company K.S.C's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: EKTTITAB's short term assets (KWD4.3M) exceed its short term liabilities (KWD3.5M).
Long Term Liabilities: EKTTITAB has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: EKTTITAB is debt free.
Reducing Debt: EKTTITAB has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EKTTITAB has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EKTTITAB has less than a year of cash runway if free cash flow continues to grow at historical rates of 1.8% each year.
Discover healthy companies
What is Ekttitab Holding Company K.S.C current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EKTTITAB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EKTTITAB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EKTTITAB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EKTTITAB's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as EKTTITAB has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Mr. Muhammad Salah Al-Ayyoob serves as Chief Executive Officer and Director at Ekttitab Holding Company K.S.C. (Public).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Ekttitab Holding Company K.S.C Public's employee growth, exchange listings and data sources
- Name: Ekttitab Holding Company K.S.C Public
- Ticker: EKTTITAB
- Exchange: KWSE
- Founded: 1999
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Implied Market Cap: د.ك3.632m
- Shares outstanding: 318.62m
- Website: https://www.ektettab.com
- Ekttitab Holding Company K.S.C Public
- Behbehani Complex
- Floor 16
- Kuwait City
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|EKTTITAB||KWSE (Kuwait Stock Exchange)||Yes||Share Capital||KW||KWD||Jan 2006|
|EKTTITAB||DFM (Dubai Financial Market)||Yes||Share Capital||AE||AED||Jan 2006|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/26 00:00|
|End of Day Share Price||2022/09/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.